Loading
Dr. Reddy's Laboratories Limited Stock: price and insider trades · India
1 insider bought shares over the last 90 days, the latest by ICICI Prudential Mutual Fund, filed 26 Aug 2026.
Insider Decl.
408
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
€6M
90 ops. · all time
Who traded when
BuySaleC Swaminathan1 sale
ICICI Prudential Mutual Fund1 buy
Analyst consensus: bullish or bearish?
Analysts rate Dr. Reddy's Laboratories Limited Hold (neutral), based on 37 analysts. Average price target: ₹1,283.65.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,241 of 26,280 companies
58.9
score / 100
Value49
Quality69
FCF yld1.8%
Earn yld4.2%
EV/EBITDA13.9x
ROE8.8%
Gross mgn53%
Net mgn13%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹1,240.00
Analyst consensus
37 analystsHold
₹1,039.00Target ₹1,283.65(+4%)₹1,740.00
Income statement
Revenue₹335.9B
Gross profit₹177.3B53% margin
EBITDA₹79.2B24% margin
Net income₹42.9B10.0% margin
Valuation
PER (trailing)31.2x
PER (forward)21.0x
P/Book2.7x
Beta0.25
Balance sheet & cash
Market cap₹1T
Total debt₹77.3B
Free Cash Flow₹18.3B
Debt / Equity19%
Profitability & ownership
ROE8.8%
ROA4.0%
% insiders30.1%
% institutions53.8%
Last declaration on 26 August 2026
Declarations408 total
712,884 shares-MarketSEBI:c14a6ea792b431e93855ceb37e7b8efb796612e6
Canonical exit: 24 Nov 2026 (T+90)
4,275 shares@ ₹1,267.80100.0% of flowAny other instrumentESOPSEBI:932cd944f3e168bee422d396b01d60d211edcd7c
3,675 shares@ ₹1,301.89990.0005% mcap42.1% of flowADR/GDR/FCCBSEBI:45230f24a84db46cc8b14b0c281a1f563076d1ee
4,275 shares@ ₹1,267.150214.0% of flowEquity SharesSEBI:822ca6b2345cf2621e60ff9466315e91affff923
4,775 shares@ ₹1,316.4057.9% of flowADR/GDR/FCCBSEBI:12397999a46a73696eb8b2cb38851e7b5df97759
10,495 shares@ ₹1,260.8011.8% of flowADR/GDR/FCCBSEBI:71816ffee125b52204b6af171b43c9529dd5ef46
7,450 shares@ ₹1,292.1012.8% of flowADR/GDR/FCCBSEBI:86d33db5422baec141b37128c053b753ec5e9f42
7,450 shares@ ₹1,291.60100.0% of flowADR/GDR/FCCBSEBI:9a07849b7fe719b923089f65397e5e5162acfe70
8,440 shares@ ₹1,325.4511.2% of flowEquity SharesSEBI:ca7e09c9c591c0642ad41a1868cf98765813d196
1,495 shares@ ₹1,325.450211.1% of flowEquity SharesSEBI:c774b42f99bc9c9c69c9dcdc47e081bdb5446006
1,250 shares@ ₹1,361.4504100.0% of flowEquity SharesSEBI:cbffd07a0456fe2014a1947757b32d1f55eba36d
2,050 shares@ ₹1,361.45372.6% of flowEquity SharesSEBI:e7334e232c6c933eee2cf3cd4dfa11e5da1224c6
1,670 shares@ ₹1,361.45036.2% of flowEquity SharesSEBI:e9ac179127cc280090adf9a413cd47f5985d558b
1,700 shares@ ₹6,651.413516.2% of flowADR/GDR/FCCBSEBI:485a090766fc1d5ae19b33ab176e9078af181b69
1,412 shares@ ₹6,553.009.1% of flowADR/GDR/FCCBSEBI:14339ac2b99aa3e6de215c668612c78ee42b8ce8
1,594 shares@ ₹6,553.0063.6% of flowADR/GDR/FCCBSEBI:c792667a8e4f2aa03d7372d7e23b406ecdcaee9e
474 shares@ ₹6,914.0019.8% of flowADR/GDR/FCCBSEBI:dd58cd6759927e0612b21c8b7723db23a8dc4704
150 shares@ ₹6,914.0047.6% of flowADR/GDR/FCCBSEBI:98fb5c592eeec2578963d0b26554f66fbdd3c543
145 shares@ ₹6,914.0033.1% of flowADR/GDR/FCCBSEBI:6fa92ed9233363a2096a34f71bebddd2f15c6897
215 shares@ ₹6,914.0036.8% of flowADR/GDR/FCCBSEBI:b2a590e11b6e5f7bb729fc2e02c09600b6647802
1,250 shares@ ₹6,914.724812.4% of flowADR/GDR/FCCBSEBI:67ec9ba677b0f9f575bd752fa42dd722f5bce9ea
704 shares@ ₹6,914.0075.3% of flowADR/GDR/FCCBSEBI:b3e7e26b4f07a30cedee660c5ff6d5bbcdb58dc0
594 shares@ ₹6,802.777811.8% of flowADR/GDR/FCCBSEBI:7ca38455e4ae5753d0bed2779c66d7c4221db444
814 shares@ ₹6,914.006.1% of flowADR/GDR/FCCBSEBI:242380ba5867de3db5bc86037cc0fc97b993c2ec
27,635 shares@ ₹16,134.78213.6% of flowADR/GDR/FCCBSEBI:5bd736ed73b8ad889442291f8e6dce5e6285d684
25 of 408 declarations
About Dr. Reddy's Laboratories Limited
At Dr. Reddy's Laboratories Limited, an Indian healthcare and pharma company, the bulk of the filings dates from 2021: 324 out of 408, against 3 in 2026. Dr. Reddy's Employees ESOS Trust is the most frequent filer, with 59 filings including 35 sales; its largest, EUR 825,794 on August 2, 2021 and EUR 436,748 on May 19, 2021, bracket Vanessa Brill's EUR 540,519 on September 14, 2023.
The record has 90 sales worth EUR 6.3 million in total (median EUR 29,712) and a single purchase, with no known amount, or 1% of open-market trades. On top come 280 grants and 37 other filings, from 144 filers. C Swaminathan filed 12 times, Anjum Swaroop 10 and Milan Kalawadia 9.
Read moreShow less
The company, listed in Bombay, is worth INR 1.0 trillion, and insiders hold 30.1%. The first publication dates from May 19, 2021 and the latest from August 26, 2026, with a median delay of 2 days. Over the last twelve months, 4 filings were published: 1 purchase and no sale.
